Anthony J Perissinotti Selected Research

Anthony J Perissinotti Research Topics

Disease

13	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 08/2014
7	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2022 - 01/2018
4	Infections 09/2022 - 01/2017
4	Leukemia 11/2021 - 01/2021
4	Neoplasms (Cancer) 04/2018 - 06/2013
2	Thrombosis (Thrombus) 11/2022 - 03/2012
2	Hemorrhage 11/2022 - 03/2012
2	Thrombocytopenia (Thrombopenia) 09/2022 - 03/2012
2	Neutropenia 09/2022 - 12/2021
2	Acute Promyelocytic Leukemia 11/2021 - 01/2021
2	Sepsis (Septicemia) 10/2021 - 12/2017
2	Philadelphia Chromosome 01/2020 - 01/2018
2	Lymphoma (Lymphomas) 01/2020 - 01/2017
2	Hypersensitivity (Allergy) 12/2019 - 01/2018
2	Acute Kidney Injury (Acute Renal Failure) 04/2019 - 04/2018
2	Cytokine Release Syndrome 09/2018 - 01/2018
2	Invasive Fungal Infections 10/2017 - 08/2014
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2021
1	Lymphopenia (Lymphocytopenia) 12/2021
1	Genetic Translocation (Chromosomal Translocation) 11/2021
1	Venous Thromboembolism 10/2021
1	Pneumonia (Pneumonitis) 08/2021
1	Obesity 01/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021
1	acquired Thrombotic thrombocytopenic purpura 10/2020
1	Multiple Myeloma 01/2020
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 04/2019
1	Critical Illness (Critically Ill) 04/2019
1	Oliguria 04/2019
1	Hodgkin Disease (Hodgkin's Disease) 01/2019
1	Tumor Lysis Syndrome 04/2018
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2018
1	Hematologic Neoplasms (Hematological Malignancy) 12/2017
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2017
1	Mycoses (Diseases, Fungus) 10/2017
1	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2017
1	Body Weight (Weight, Body) 07/2015
1	Ductal Carcinoma 06/2013
1	Death (Near-Death Experience) 06/2013
1	Meningeal Carcinomatosis 10/2010

Drug/Important Bio-Agent (IBA)

4	Asparaginase (Elspar)FDA Link 11/2022 - 01/2018
4	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021 - 12/2016
3	blinatumomabIBA 01/2020 - 01/2018
2	pegaspargase (Oncaspar)FDA Link 11/2022 - 01/2018
2	Bendamustine Hydrochloride FDA Link 12/2021 - 04/2019
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 11/2021 - 01/2021
2	Vincristine (Oncovin)FDA LinkGeneric 01/2021 - 01/2020
2	Pharmaceutical PreparationsIBA 12/2019 - 01/2018
2	posaconazole FDA Link 10/2017 - 07/2015
2	TabletsIBA 10/2017 - 07/2015
2	Trastuzumab (Herceptin)FDA Link 06/2013 - 10/2010
1	Retinoic Acid Receptor alphaIBA 11/2021
1	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2021
1	Prednisone (Sone)FDA LinkGeneric 01/2021
1	Azacitidine (5 Azacytidine)FDA Link 01/2021
1	caplacizumabIBA 10/2020
1	elotuzumabIBA 01/2020
1	Lenalidomide (CC 5013)FDA Link 01/2020
1	daratumumabIBA 01/2020
1	fms-Like Tyrosine Kinase 3IBA 09/2019
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2019
1	Chimeric Antigen ReceptorsIBA 09/2018
1	CD19 AntigensIBA 09/2018
1	rasburicase (Elitek)FDA Link 04/2018
1	Uric Acid (Urate)IBA 04/2018
1	Daptomycin FDA Link 12/2017
1	Vancomycin FDA LinkGeneric 12/2017
1	idelalisibIBA 10/2017
1	ibrutinibIBA 10/2017
1	Monoclonal AntibodiesIBA 10/2017
1	obinutuzumabIBA 10/2017
1	SuspensionsIBA 10/2017
1	venetoclaxIBA 10/2017
1	Levofloxacin (Levaquin)FDA Link 01/2017
1	BilirubinIBA 12/2016
1	AnthracyclinesIBA 12/2016
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 04/2015
1	AntigensIBA 04/2015
1	EchinocandinsIBA 08/2014
1	human ERBB2 proteinIBA 06/2013
1	Heparin (Liquaemin)FDA LinkGeneric 03/2012
1	Fondaparinux (Arixtra)FDA Link 03/2012
1	Rituximab (Mabthera)FDA Link 10/2010

Therapy/Procedure

15	Therapeutics 01/2022 - 06/2013
9	Drug Therapy (Chemotherapy) 01/2022 - 01/2017
3	Immunotherapy 01/2020 - 01/2018
2	Renal Dialysis (Hemodialysis) 04/2019 - 04/2018
2	Induction Chemotherapy 01/2018 - 12/2017
1	Patient Readmission 09/2022
1	Catheters 10/2021
1	Central Venous Catheters 10/2021
1	Plasma Exchange 10/2020
1	Premedication 12/2019
1	Remission Induction 05/2019
1	Chest Tubes (Chest Tube) 03/2012
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 03/2012